Highlights Microbot Medical Inc.

Equities

MBOT

US59503A2042

Delayed Nasdaq Other stock markets 18:33:59 10/05/2024 BST			5-day change	1st Jan Change
0.9201 ^USD	+0.01%		-6.09%	-43.90%

04-29	Microbot Medical Announces Positive Results from the First Phase of Its Collaboration with Corewell Health	CI
04-16	HC Wainwright Adjusts Microbot Medical's Price Target to $7 From $8, Keeps Buy Rating	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Microbot Medical Announces Positive Results from the First Phase of Its Collaboration with Corewell Health	04-29	CI
Microbot Medical Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-27	CI
Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the US	02-05	CI
Microbot Medical Expands US Clinical Infrastructure in Support of the Upcoming IDE Submission to Commence its First in Human Clinical Study	01-18	CI
Microbot Medical Announces Positive Results of Its GLP Pivotal Pre-Clinical Study Where All Study Objectives Met	12-28	CI
Microbot Medical and Corewell Health Forge Collaboration to Establish the LIBERTY Endovascular Robotic Surgical System for Telerobotic	12-14	CI
Microbot Medical Announces the Successful Completion of its GLP Pivotal Pre-Clinical Study	12-07	CI
Microbot Medical Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-14	CI
Microbot Medical Inc. Successfully Completed Integral Part of the Verification and Validation Process	11-13	CI
Microbot Medical Gets Registered Trademark From US Patent and Trademark Office	11-08	MT
Microbot Medical Inc. Approves Ratification of Brightman Almagor Zohar & Co. as Independent Registered Public Accounting Firm	11-06	CI
Microbot Medical Reveals Successful Short Term Follow Up Outcomes from Its Pivotal Pre-Clinical Study	31/10/23	CI
Microbot Medical Says Court Dismisses Counterclaim Against Company in Short-Swing Lawsuit	19/10/23	MT
Microbot Medical Inc. Announces Successful Initial Outcomes from its Pivotal Pre-Clinical Study with the LIBERTY Robotic Surgical System	17/10/23	CI
Microbot Medical Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23	CI
Microbot Medical Inc. Announces Successful Completion of Two-Day Pre-Clinical Study Held by Leading Opinion Leaders At A New York-Based Research Lab	29/06/23	CI
Microbot Medical Inc. Announces the Expansion of its Global IP Portfolio by Receiving a Grant of Protection from the Japan Patent Office	22/06/23	CI
Microbot Medical Receives Grant From Israel Innovation Authority to Support Manufacturing Process for Robotic Surgical System	02/06/23	MT
LIBERTY Robotic Surgical System Achieved Additional Milestone in its Path to First in Human and Regulatory Process	31/05/23	CI
Microbot Medical Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	17/05/23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Microbot Medical Inc.

Equities

MBOT

US59503A2042

Highlights

Filters